Drug information
GLP-1 Medications
Compare the major GLP-1 medications side by side. All data sourced from FDA prescribing information.
- FDA-sourced
- Peer-reviewed
- Updated weekly
Side-by-side comparison
Compare two GLP-1 medications
Pick any two — we render head-to-head efficacy, cost, side effects, and dosing.
Most searched
Pivotal-trial weight loss compared
Mean total-body-weight reduction reported by each medication’s pivotal Phase 3 trial. Different trial populations, durations, and dosing make exact head-to-head comparison imperfect — but the magnitude differences are real.
Active ingredients sourced from 4 editorial entries; see /ingredients for per-molecule breakdowns.
GLP-1 receptor agonist (daily injection)
Saxenda
Generic: liraglutide
Novo Nordisk
~$1349.00/mo
GLP-1 receptor agonist
Wegovy
Generic: semaglutide
Novo Nordisk
~$1349.02/mo
GLP-1 receptor agonist
Ozempic
Generic: semaglutide
Novo Nordisk
~$935.77/mo
GLP-1 receptor agonist
Ozempic
Generic: semaglutide
Novo Nordisk
~$997.58/mo
GLP-1 receptor agonist
Wegovy HD
Generic: semaglutide 7.2 mg
Novo Nordisk
~$1349.00/mo
GLP-1 receptor agonist (oral tablet)
Rybelsus
Generic: semaglutide (oral)
Novo Nordisk
~$1029.00/mo
GIP/GLP-1 dual receptor agonist
Zepbound
Generic: tirzepatide
Eli Lilly
~$1059.87/mo
GIP/GLP-1 dual receptor agonist
Mounjaro
Generic: tirzepatide
Eli Lilly
~$1023.04/mo